Avoiding Lag: Real-Time Signals in (PLXS) Movement
This article provides a real-time analysis of Plexus Corp. (NASDAQ: PLXS) stock movement, highlighting a weak near-term sentiment despite long-term strength. It details an exceptional 41.7:1 risk-reward setup targeting a 12.0% gain. The report offers institutional trading strategies, including position trading, momentum breakout, and risk hedging, based on AI-generated signals and multi-timeframe analysis.
How Investors May Respond To Plexus (PLXS) Being Dropped From Multiple Russell Value Benchmarks
Plexus Corp. (PLXS) was recently removed from several Russell value and small-cap benchmarks, which may trigger forced trading by tracking funds. While this primarily affects share ownership rather than business operations, investors should consider how this impacts the stock's risk profile, especially concerning customer concentration and program timing. The company also secured a new US$500 million revolving credit facility, offering financial flexibility despite potential short-term share price volatility.
How Investors May Respond To Plexus (PLXS) Being Dropped From Multiple Russell Value Benchmarks
Plexus Corp. (PLXS) was recently removed from several Russell value and small-cap benchmarks, an event that could lead to significant shifts in its ownership and trading patterns due to forced buying and selling by tracking funds. Despite the index changes not directly affecting Plexus's business operations or near-term catalysts, investors should consider how these shifts intersect with the company's existing risks, such as customer concentration and program timing. Simply Wall St's analysis projects a fair value for Plexus at $280.75, which suggests a 3% downside from its current price, inviting investors to conduct further research into its financial health and risk profile.
PLXS - Plexus Corp Options
This article provides a detailed financial overview of Plexus Corp (PLXS), including its stock performance, key financial ratios, and analyst recommendations. It highlights the company's valuation metrics, earnings per share growth, and institutional ownership, along with information on options trading for the stock.
Plexus Corp (PLXS) Stock Up 4.4% but GF Value Says Overvalued -- GF Score: 83/100
Plexus Corp (PLXS) shares increased by 4.4% to $300.67, but GuruFocus's GF Value™ indicates the stock is 102.5% overvalued compared to its intrinsic value of $148.51. Despite a strong GF Score™ of 83/100, driven by excellent growth and profitability, the valuation score is very low (1/10). Furthermore, insiders have sold $6.0 million in shares over the last three months, suggesting a lack of confidence in the current valuation.
Louisiana State Employees Retirement System Invests $2.41 Million in Plexus Corp. $PLXS
The Louisiana State Employees Retirement System has invested $2.41 million in Plexus Corp. (NASDAQ:PLXS), acquiring 11,900 shares in the first quarter. Despite the stock trading near its 52-week high, analysts maintain a "Moderate Buy" rating, anticipating continued growth. Plexus recently reported strong quarterly results, exceeding EPS and revenue estimates, with Q3 2026 EPS guidance set between $2.02 and $2.18.
Plexus Corp.(NasdaqGS: PLXS) dropped from Russell 2000 Value Benchmark
Plexus Corp. (NasdaqGS:PLXS) has been removed from the Russell 2000 Value Benchmark. This news follows several insider share sales, the latest earnings report showing increased revenue and adjusted earnings, and recent partnerships. The company provides design, manufacturing, and supply chain solutions for various sectors including aerospace, defense, and medical.
PX4 Forecast — Price Target — Prediction for 2027
This article provides a forecast for Plexus Corp. (PX4), outlining analyst price targets, historical highs and lows, and upcoming financial reports. It details the company's recent earnings and revenue, its current EBITDA, and confirms that PX4 does not pay dividends.
Plexus Corp. Actuals & Estimates (NASDAQ:PLXS)
This article provides a detailed overview of Plexus Corp. (NASDAQ: PLXS) stock, including its current price, historical performance, analyst forecasts, and financial data. It highlights key metrics such as market capitalization, revenue, earnings per share, and EBITDA, along with frequently asked questions about investing in the company.
Plexus Corp stock hits all-time high of 305.67 USD
Plexus Corp (PLXS) stock reached an all-time high of $305.67, trading just under its 52-week high with a market capitalization of approximately $8 billion, reflecting a 124.35% surge over the last year. Despite a P/E ratio of 43.81 indicating potential overvaluation, the company recently reported strong Q2 2026 financial results, surpassing earnings and revenue forecasts, and secured a new $500 million credit agreement. Analysts at Needham and Stifel have reiterated Buy ratings, raising price targets due to confidence in Plexus's growth trajectory and market positioning.
The Bull Case For Plexus (PLXS) Could Change Following Its Expanded Long-Term Credit Facility - Learn Why
Plexus Corp. has secured an expanded long-term credit facility, replacing its 2022 agreement with a revolving credit line maturing in June 2031, with commitments increasing from US$500 million to US$750 million. This new facility offers enhanced financial flexibility, supporting Plexus's growth capacity for complex electronic manufacturing services, particularly in healthcare, industrial, and aerospace and defense sectors. While it modestly improves liquidity and acquisition capacity, the article emphasizes that the core investment narrative remains focused on program execution, and awareness of concentrated customer demand and sector cyclicality is still crucial for investors.
The Bull Case For Plexus (PLXS) Could Change Following Its Expanded Long-Term Credit Facility - Learn Why
Plexus Corp. has secured an expanded long-term credit facility, increasing its revolving credit line from J.P. Morgan Chase to potentially US$750 million, maturing in June 2031. This move enhances Plexus's financial flexibility and capacity for acquisitions, though the immediate investment narrative still hinges on program execution and managing risks like customer concentration. Investors should monitor how this improved liquidity supports complex defense and intelligence programs while being aware of continued revenue exposure to large customers and sector cyclicality.
Plexus Corp (PLXS) CEO sells 1,500 shares under Rule 10b5-1 plan
Plexus Corp (PLXS) President & CEO Todd P. Kelsey sold 1,500 shares of common stock on June 17, 2026, as part of a pre-arranged Rule 10b5-1 trading plan. The shares were sold at prices ranging from $292.1085 to $296.0900 per share, totaling approximately $442,464. Following these transactions, Kelsey directly owns 68,888 shares of Plexus common stock.
Plexus Corp (PLXS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article provides a revenue breakdown for Plexus Corp (PLXS), detailing its financial performance by business segments and regions. As of FY2026Q1, the company's revenue is primarily driven by Healthcare/Life Sciences, Industrial, and Aerospace/Defense sectors. Regional revenue and profit contribution data were not disclosed.
Plexus Corp (PLXS) Dividends & Stock Splits: Historical Payouts and Event Timeline
The article provides a historical overview of Plexus Corp's (PLXS) dividends and stock splits. It states that no dividend data is available for the past five years and no stock split events have been recorded. The page also presents current stock performance data, including market cap and P/E ratio for PLXS.
Kennedy Capital Management LLC Increases Stake in Plexus Corp. $PLXS
Kennedy Capital Management LLC significantly increased its stake in Plexus Corp. (NASDAQ:PLXS) by 20.1% in the fourth quarter, purchasing 13,020 additional shares and bringing its total holding to 77,828 shares valued at approximately $11.44 million. Institutional ownership of Plexus remains very high at 94.45%, with other firms also adding to or initiating positions. Meanwhile, several company insiders, including Michael J. Running and Victor (Pang Hau) Tan, sold shares, while analysts maintain a "Moderate Buy" rating with an average target price of $238.33.
Plexus Corp stock hits all-time high at 299.0 USD By Investing.com
Plexus Corp stock reached an all-time high of $299, marking a 122.82% increase over the past year. Despite its strong performance and positive analyst outlook, with Needham and Stifel reiterating Buy ratings and raising price targets, InvestingPro analysis suggests the stock might be overvalued relative to its Fair Value estimate. The company also announced impressive fiscal Q2 2026 results and a new $500 million credit agreement.
Behavioral Patterns of PLXS and Institutional Flows
This article analyzes Plexus Corp. (NASDAQ: PLXS)'s behavioral patterns and institutional flows. It highlights a near-term neutral sentiment amidst mid and long-term strength, with a breakout underway and no resistance levels above the current price. The analysis provides key signals, institutional trading strategies (position, momentum breakout, and risk hedging), and multi-timeframe signal analysis generated by AI models.
Plexus Corp stock hits all-time high at 299.0 USD By Investing.com
Plexus Corp (PLXS) stock reached an all-time high of $299, marking a 122.82% increase over the past year. Despite this surge and investor confidence, InvestingPro analysis suggests the stock might be overvalued with a P/E ratio of 42.09 compared to its Fair Value estimate. The company recently reported strong Q2 2026 financial results, surpassing earnings and revenue forecasts, and secured a new $500 million credit agreement, leading analysts like Needham and Stifel to maintain "Buy" ratings with raised price targets.
Plexus Corp stock hits all-time high at 299.0 USD By Investing.com
Plexus Corp (PLXS) stock has reached an all-time high of $299.00 USD, marking a 122.82% increase over the past year. Despite its strong performance and positive analyst outlooks, with Needham and Stifel reiterating Buy ratings and raising price targets, InvestingPro analysis suggests the stock is currently overvalued. The company recently reported strong fiscal Q2 2026 results and secured a new $500 million credit agreement.
Plexus Corp stock hits all-time high at 299.0 USD By Investing.com
Plexus Corp (PLXS) stock has reached an all-time high of $299, marking a 122.82% increase over the past year. Despite its strong performance, with a P/E ratio of 42.09, InvestingPro analysis indicates the stock may be overvalued relative to its Fair Value. The company recently reported strong fiscal Q2 2026 results, surpassing earnings and revenue forecasts, and secured a new $500 million credit agreement, leading analysts like Needham and Stifel to maintain positive ratings and raise price targets.
Plexus Corp stock hits all-time high at 299.0 USD
Plexus Corp's stock has surged to an all-time high of $299, marking a 122.82% increase over the past year, reflecting strong investor confidence and growth. Despite its current P/E ratio suggesting it may be overvalued, the company recently reported strong fiscal Q2 2026 results, exceeding earnings and revenue forecasts, and secured a new $500 million credit agreement. Analyst firms Needham and Stifel have reinforced their positive outlooks, maintaining Buy ratings and raising price targets for Plexus.
Plexus' Q2 earnings surpass estimates, revenues increase Y/Y
Plexus (NASDAQ: PLXS) reported strong Q2 earnings, with both revenue and EPS exceeding analyst expectations. The company saw a year-over-year increase in revenues and projects its Q3 performance to be between $980 million and $1.02 billion.
Hodges Capital Management Inc. Buys 5,795 Shares of Plexus Corp. $PLXS
Hodges Capital Management Inc. significantly increased its stake in Plexus Corp. (NASDAQ:PLXS) by 47.7% in the fourth quarter, acquiring an additional 5,795 shares to bring its total holding to 17,950 shares valued at $2.64 million. Several other institutional investors also increased their positions, contributing to 94.45% of Plexus shares being institutionally owned. Despite a "Moderate Buy" consensus rating from analysts, the company's Q4 earnings beat estimates, with reported EPS of $2.05 against a consensus of $1.87 and revenue of $1.16 billion.
The Bull Case For Plexus (PLXS) Could Change Following Major Credit Facility Expansion - Learn Why
Plexus Corp. recently expanded its credit facility to US$500 million, extendable to US$750 million, and pushed the maturity to 2031, granting it significant financial flexibility for operations and expansion. This move could alter its investment narrative and risk profile, particularly as it pursues high-complexity programs in healthcare, industrial, and aerospace and defense sectors. While the credit line offers flexibility, investors should still consider the implications of rising working capital and inventory levels.
Plexus Corp. enters new $500 million credit agreement maturing in 2031
Plexus Corp. announced a new $500 million revolving credit agreement, replacing its previous one. The facility matures in June 2031 and includes an option to increase the commitment by $250 million. The company reported strong financial results for Q2 2026, exceeding earnings and revenue forecasts, and maintaining debt levels within covenant requirements.
Insider Sell: Michael Running Sells 510 Shares of Plexus Corp (P
Michael Running, Regional President - AMER of Plexus Corp (PLXS), sold 510 shares of the company on June 5, 2026. This transaction reduces his holding to 665 shares. Plexus Corp's stock is currently trading at $272.17, leading to a market cap of $7.553 billion, and is considered significantly overvalued based on its GF Value of $147.12.
Plexus Corp (PLXS) Stock Up 3.4% but GF Value Says Overvalued -- GF Score: 81/100
Plexus Corp (PLXS) stock rose 3.4% to $282.29, marking significant year-to-date and past-year gains. Despite a strong GF Score of 81/100, the stock is considered "Significantly Overvalued" by GuruFocus's GF Value, trading 91.9% above its intrinsic value estimate. This overvaluation is further supported by a P/E ratio significantly higher than its historical median, and insider selling of $5.7 million worth of shares adds to concerns about future performance.
Plexus Corp. enters new $500 million credit agreement maturing in 2031
Plexus Corp. announced a new $500 million credit agreement maturing in 2031, replacing a previous one from 2022. The facility offers a revolving commitment with an option to increase by $250 million and includes financial covenants requiring specific interest coverage and leverage ratios. This news follows strong financial results for fiscal Q2 2026 and positive analyst outlooks, despite an InvestingPro Fair Value analysis suggesting the stock is overvalued.
Plexus regional president Michael Running sells $138,804 in stock
Michael J. Running, Regional President at PLEXUS CORP, sold 510 shares of the company's common stock for over $138,000 on June 5, 2026, reducing his direct holdings to 665 shares. This insider transaction occurred while Plexus shares were trading near their 52-week high, having delivered a 105% return over the past year. The company recently reported strong fiscal Q2 2026 results, surpassing earnings and revenue forecasts, and analysts from Needham and Stifel have maintained positive outlooks with raised price targets.
Plexus Corp (PLXS) Regional President Running sells 510 shares in open market
Plexus Corp's Regional President - AMER, Michael J. Running, sold 510 shares of the company's common stock in an open-market transaction at an average price of $272.165 per share. Following this sale, he directly holds 665 shares. The transaction, valued at approximately $139,000, was reported via a Form 4 SEC filing on June 8, 2026.
Plexus Inks $500 Million Revolving Credit Facility With JPMorgan; Maturity in 2031
Plexus has secured a $500 million revolving credit facility, expandable to $750 million, with JPMorgan Chase Bank, maturing on June 5, 2031. This agreement enhances the company's liquidity and financial flexibility for general corporate purposes and growth initiatives. The facility includes financial covenants such as minimum interest coverage and maximum leverage ratios.
Plexus Corp. (NASDAQ: PLXS) renews $500M revolver with expansion option
Plexus Corp. (NASDAQ: PLXS) has renewed its revolving credit facility, establishing a new $500 million agreement maturing on June 5, 2031, which replaces a previous 2022 agreement. This facility includes an expansion option that could increase the total commitment to $750 million. The agreement outlines interest rates tied to various benchmarks and contains financial covenants, including a minimum interest coverage ratio of 3.00 to 1.00 and a maximum leverage ratio of 3.50 to 1.00.
Geode Capital Management LLC Raises Stake in Plexus Corp. $PLXS
Geode Capital Management LLC increased its stake in Plexus Corp. (NASDAQ:PLXS) by 0.6% in the fourth quarter, bringing its total holdings to 672,614 shares valued at $98.9 million. This increase follows Plexus reporting better-than-expected quarterly results, with EPS of $2.05 and revenue of $1.16 billion. Analysts currently maintain a "Moderate Buy" consensus rating with a price target of $238.33 for the company.
PLXS Financials: Revenue Breakdown, Margins & Competitor Comparison
Plexus Corp (PLXS) generates its revenue primarily from Healthcare/Life Sciences, accounting for 43.6% ($466.03M) of total sales, with Industrial and Aerospace/Defense also contributing significantly. The company maintains a gross margin of 10.24%, an operating margin of 5.31%, and a net margin of 4.28%, alongside a 13.20% Return on Equity. When compared to competitors like VSH and AXTI, PLXS's gross margin is lower, indicating potential differences in pricing power or manufacturing efficiency within the Electronic Equipment & Parts industry.
PLXS affiliate schedules common-stock sale via Morgan Stanley (NASDAQ: PLXS)
An affiliate of Plexus Corp (PLXS) has filed a Form 144 to notify a proposed sale of Common Stock through Morgan Stanley Smith Barney LLC. The filing details the sale of 249 Performance Stock Units from November 2023 and 261 Restricted Stock Units from January 2024. This is a routine regulatory filing, and no sale proceeds or pricing information are disclosed in the document itself.
Insider Sell: Todd Kelsey Sells 1,000 Shares of Plexus Corp (PLXS)
Plexus Corp's President & CEO, Todd Kelsey, sold 1,000 shares of the company on June 3, 2026, reducing his holdings to 70,388 shares. This sale is part of a pattern of insider selling at Plexus, with 42 insider sells and no buys over the past year. The stock is currently trading at $290, significantly above its GF Value of $146.81, indicating it is overvalued.
Plexus Corp president & CEO sells $290,000 in common stock
Plexus Corp's President & CEO, Todd P. Kelsey, sold 1,000 shares of common stock for $290,000 on June 3, 2026. This transaction occurred as PLXS stock is near its 52-week high, although InvestingPro analysis suggests it may be overvalued. The company recently reported strong fiscal Q2 2026 results, exceeding earnings and revenue expectations, and has received positive analyst ratings from Needham and Stifel, who raised price targets and reiterated Buy ratings.
Plexus (PLXS) CEO Todd Kelsey sells 1,000 common shares in open market
Plexus Corp's President & CEO, Todd P. Kelsey, sold 1,000 shares of common stock in an open-market transaction at $290.00 per share. After this sale, Kelsey directly holds 70,388 shares. This transaction, totaling $290,000, was reported in an SEC Form 4 filing and is considered a relatively small disposition compared to his remaining stake.
Plexus Corp president & CEO sells $290,000 in common stock
Plexus Corp's President & CEO, Todd P. Kelsey, sold 1,000 shares of common stock for $290,000 on June 3, 2026. This transaction occurred as PLXS stock neared its 52-week high, having returned 118% over the past year. The company recently reported strong financial results for Q2 2026, exceeding revenue and EPS forecasts, and received positive analyst sentiment with Needham raising its price target to $310 and Stifel reiterating a Buy rating.
Insider sale notices for PLXS (NASDAQ: PLXS)
This article details proposed and completed insider sales of Plexus Corp (PLXS) common stock and performance stock units, as reported in a Form 144 SEC filing. The filing lists sales by Todd P. Kelsey and a trust associated with Kelly M. Liv, including specific dates, share counts, and gross proceeds from transactions in 2026. Key figures include 1000 Performance Stock Units and several common stock sales with gross proceeds ranging from $274,750.00 to $805,350.00.
Plexus Corp (PLXS) director’s 500-share Rule 10b5-1 sale disclosed
Plexus Corp director Karen Marie Rapp sold 500 shares of common stock at $270.00 per share under a pre-arranged Rule 10b5-1 trading plan adopted on February 2, 2026. Following this transaction, Rapp directly holds 8,035 Plexus shares. The Form 4 filing indicates an open-market sale with a "S" transaction code.
Plexus Issues Fiscal 2025 Sustainability Report and Announces Transition to Absolute Emission Reduction Targets
Plexus Corp. announced the release of its Fiscal 2025 Sustainability Report, detailing its commitment to transparency and sustainable practices. A key highlight is the company's formal transition from intensity-based to absolute emissions reduction targets, aligning with international standards. The report also covers achievements in circularity, social impact, team member well-being, and streamlined reporting, demonstrating Plexus's dedication to environmental, social, and corporate governance.
[144] PLEXUS CORP SEC Filing
This article provides details of a Form 144 SEC filing by Plexus Corp (PLXS), indicating a proposed sale of securities. The filing impact and sentiment are noted as "Neutral." The document outlines information about the filer, issuer, and the specific securities to be sold, including details of their acquisition.
PLXS Maintained by Needham -- Price Target Raised to $310
Needham has maintained its 'Buy' rating for Plexus Corp (PLXS) and raised its price target from $285.00 to $310.00. Despite this analyst confidence, GuruFocus indicates that PLXS is significantly overvalued by 83.3% based on its GF Value™ of $146.44 compared to its market price of $268.38. Insider activity also shows a selling trend, with insiders offloading $5.3 million worth of shares in the last three months, suggesting caution for potential investors.
Plexus doubles zero-waste sites, commits to cut emissions by 2033
Plexus has released its Fiscal 2025 Sustainability Report, announcing a transition from intensity-based metrics to absolute emissions reduction targets by 2033. The company has more than doubled its zero-waste sites to eight global locations and contributed over $1.4 million to community causes. Additionally, Plexus has enhanced mental health support for its team members, providing care four times faster than traditional programs.
Needham & Company LLC Issues Positive Forecast for Plexus (NASDAQ:PLXS) Stock Price
Needham & Company LLC has raised its price target for Plexus (NASDAQ:PLXS) from $285 to $310, reiterating a "buy" rating and implying a 15.5% upside. This positive forecast follows Plexus's better-than-expected Q2 results, with EPS of $2.05 against an estimated $1.87 and revenue of $1.16 billion, exceeding the $1.13 billion estimate and showing an 18.7% year-over-year increase. Despite recent insider selling, institutional ownership remains high at 94.45% of the company's stock, and Plexus has an average "Moderate Buy" rating from analysts.
Plexus CEO Todd Kelsey sells $274,750 of company stock
Plexus CEO Todd P. Kelsey sold 1,000 shares of company stock for $274.75 per share, totaling $274,750. This transaction occurred as the stock traded near its 52-week high, following impressive recent financial results for fiscal Q2 2026 and a reiterated Buy rating from Stifel. Despite positive developments, Plexus shares saw a decline in after-hours trading.
Plexus CEO Todd Kelsey sells $274,750 of company stock
Plexus CEO Todd Kelsey sold 1,000 shares of PLEXUS CORP (NASDAQ:PLXS) common stock for $274.75 per share, totaling $274,750, as the stock traded near its 52-week high. Following the sale, Kelsey directly owns 71,388 shares. This insider transaction occurred after the company reported strong Q2 2026 financial results, though its stock saw a decline in after-hours trading despite a "Buy" rating from Stifel.
Plexus Insider Sold Shares Worth $274,750, According to a Recent SEC Filing
An insider at Plexus Corp. sold shares valued at $274,750, according to a recent SEC filing. This transaction occurred on May 29, 2026. The article highlights other recent insider share sales and notes that Plexus provides design, supply chain, manufacturing, and sustaining services across various sectors.
